Bromocriptine, a dopamine analog, has been suggested be beneficial in protecting the SLE patients from disease relapse and in reducing the usage of steroid and immunosuppressant by suppressing the circulating prolactin [31]–[33]. This evidence concerns the gene PRL and systemic lupus erythematosus.